Abstract The Cervical Screening Cohort enrols women screened for human papillomavirus
(HPV) and cervical abnormalities within the capital region of Sweden from the organised …

Background: New screening technologies and vaccination against human papillomavirus
(HPV), the necessary cause of cervical cancer, may impact optimal approaches to prevent …

Cervical cancer screening in Europe: what next? - ScienceDirect Skip to main contentSkip to
article Elsevier logo Journals & Books Search RegisterSign in View PDF Download full issue …

Objectives We modelled human papilloma virus (HPV) primary screening scenarios
compared with Pap cytology to evaluate clinical effectiveness and projected annual costs in …

Evaluation of Human Papillomavirus (HPV) testing systems suitable for large-scale
organized cervical screening programs is required. We evaluated the cobas 6800 HPV test …

Objective Several studies have shown that there is an upward shift in the classification of
cervical cytology when high-risk human papillomavirus (hrHPV) status is known to be …

Background HPV test appears to be more effective in cervical cancer (CC) screening.
However, the decision of its adoption as a primary screening method by substituting the …

Introduction Primary HPV screening will be implemented into the English Cervical Screening
Programme by 2019. Its impact upon women referred to colposcopy, with negative cytology …

Background In 2017, the Dutch cervical cancer screening program had replaced the primary
cytology-based screening with primary high-risk human papillomavirus-based screening …

Background: Human papillomavirus (HPV) testing is more sensitive than cytology for
detecting high-grade cervical intraepithelial neoplasia (CIN). We evaluated the performance …